Some shareholders support acquisition of rare disease specialist Alexion
Home/FT/AstraZeneca shares fall on investor concern over $39bn deal FT AstraZeneca shares fall on investor concern over $39bn deal Financial Times0 Less than a minute Facebook X LinkedIn Some shareholders support acquisition of rare disease specialist Alexion Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
